✦ LIBER ✦

Recent corticosteroid use and recent disease activity: Independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?

✍ Scribed by Karp, Igor ;Abrahamowicz, Michal ;Fortin, Paul R. ;Pilote, Louise ;Neville, Carolyn ;Pineau, Christian A. ;Esdaile, John M.

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 86 KB
Volume: 59
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.23352

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for coronary heart disease

Risk factors for coronary heart disease in women with systemic lupus erythematosus: The Toronto Risk Factor Study

✍ Ian N. Bruce; Murray B. Urowitz; Dafna D. Gladman; Dominique Ibañez; George Stei 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

Risk factors for damage in childhood-ons

Risk factors for damage in childhood-onset systemic lupus erythematosus: Cumulative disease activity and medication use predict disease damage

✍ Hermine I. Brunner; Earl D. Silverman; Theresa To; Claire Bombardier; Brian M. F 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

Systemic lupus erythematosus in a multie

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients

✍ Jaime Calvo-Alén; Sergio M. A. Toloza; Mónica Fernández; Holly M. Bastian; Barri 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

## Abstract ## Objective Venous thrombosis is a relatively frequent and serious complication in systemic lupus erythematosus (SLE) that has been associated with the presence of antiphospholipid antibodies (aPL). However, venous thrombotic events can also be seen in patients without aPL, and only a